Monalizumab Biosimilar - Onderzoeksgraad

[NKG2A]

3821

Human

This biosimilar is stable when stored at 2-8 degree C. For longer term storage (> 3 months) it is recommended to store this antibody at -20 degree C or -70 degree C.

Detects human CD159a. This non-therapeutic antibody uses the same sequence as the therapeutic antibody Monalizumab.

[KLRC1; KLRC1; NKG2; NKG2A; CD159A; NKG2A]

[Monalizumab]

[NKG2-A/NKG2-B type II integral membrane protein isoform NKG2-A; NKG2-A/NKG2-B type II integral membrane protein; NKG2-A/NKG2-B type II integral membrane protein; NK cell receptor A; C-lectin type II protein; natural killer cell lectin; natural killer group protein 2; NKG2-1/B activating NK receptor; NKG2-A/B-activating NK receptor; CD159 antigen-like family member A; killer cell lectin-like receptor subfamily C, member 1; CD159 antigen-like family member A; NK cell receptor A; NKG2-A/B-activating NK receptor]

4504881

NP_002250.1

NM_002259.4

P26715